Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
May. 15 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Sales 2022 | 1.28M 858K | Sales 2023 | 892K 597K | Capitalization | 15.07M 10.09M |
---|---|---|---|---|---|
Net income 2022 | -7M -4.68M | Net income 2023 | -6M -4.02M | EV / Sales 2022 | 9.63 x |
Net cash position 2022 | 4.07M 2.72M | Net cash position 2023 | 226K 151K | EV / Sales 2023 | 16.6 x |
P/E ratio 2022 |
-2.29
x | P/E ratio 2023 |
-2.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.64% |
Managers | Title | Age | Since |
---|---|---|---|
Kerem Kaya
DFI | Director of Finance/CFO | - | 21-05-12 |
Jeremy Henson
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
David A. Rutolo
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Hudson
BRD | Director/Board Member | - | 23-03-05 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.06M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- MDC Stock